LIPIDSOL Trademark
Trademark Overview
On Wednesday, November 23, 2022, a trademark application was filed for LIPIDSOL with the United States Patent and Trademark Office. The USPTO has given the LIPIDSOL trademark a serial number of 97690235. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Tuesday, May 20, 2025. This trademark is owned by Ascendia Pharmaceuticals, Inc.. The LIPIDSOL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
pharmaceutical drug development services in the field of nanoparticles and liposomes; pharmaceutical research and development; pharmaceutical research services
General Information
| Serial Number | 97690235 |
| Word Mark | LIPIDSOL |
| Filing Date | Wednesday, November 23, 2022 |
| Status | 819 - SU - REGISTRATION REVIEW COMPLETE |
| Status Date | Tuesday, May 20, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 17, 2023 |
Trademark Statements
| Goods and Services | pharmaceutical drug development services in the field of nanoparticles and liposomes; pharmaceutical research and development; pharmaceutical research services |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 16, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | Sunday, April 30, 2023 |
| First Use In Commerce Date | Sunday, April 30, 2023 |
Trademark Owner History
| Party Name | Ascendia Pharmaceuticals, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | North Brunswick, NJ 08902 |
| Party Name | Ascendia Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | North Brunswick, NJ 08902 |
Trademark Events
| Event Date | Event Description |
| Friday, December 16, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, November 26, 2022 | NEW APPLICATION ENTERED |
| Tuesday, September 5, 2023 | ASSIGNED TO EXAMINER |
| Monday, September 11, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, September 27, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, June 12, 2024 | USE AMENDMENT FILED |
| Wednesday, June 12, 2024 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, October 17, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 17, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 12, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, July 29, 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| Tuesday, May 20, 2025 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, May 20, 2025 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Monday, July 29, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
